Clinical Trials Browser

Phase 1 × Localized Muscle Invasive Bladder Urothelial Carcinoma × 90 days × Clear all

NCT05833867 2026-03-13

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Phase 1 Recruiting

Localized Muscle Invasive Bladder Urothelial Carcinoma